CN105012725B - 一种治疗骨髓增生异常综合症的中药组合物及其制备方法 - Google Patents
一种治疗骨髓增生异常综合症的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN105012725B CN105012725B CN201510286547.7A CN201510286547A CN105012725B CN 105012725 B CN105012725 B CN 105012725B CN 201510286547 A CN201510286547 A CN 201510286547A CN 105012725 B CN105012725 B CN 105012725B
- Authority
- CN
- China
- Prior art keywords
- radix
- blood
- treatment
- myelodysplastic syndrome
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 201000003793 Myelodysplastic syndrome Diseases 0.000 title claims abstract description 18
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 238000011282 treatment Methods 0.000 claims abstract description 31
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 15
- 241000282817 Bovidae Species 0.000 claims abstract description 14
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 14
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 14
- 239000010231 banlangen Substances 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims description 22
- 239000011812 mixed powder Substances 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 235000020985 whole grains Nutrition 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 24
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 description 49
- 239000008280 blood Substances 0.000 description 49
- 201000010099 disease Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 102000001554 Hemoglobins Human genes 0.000 description 13
- 108010054147 Hemoglobins Proteins 0.000 description 13
- 208000032843 Hemorrhage Diseases 0.000 description 11
- 208000034158 bleeding Diseases 0.000 description 11
- 230000000740 bleeding effect Effects 0.000 description 11
- 210000001772 blood platelet Anatomy 0.000 description 11
- 206010037660 Pyrexia Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 208000007502 anemia Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000023597 hemostasis Effects 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 210000001185 bone marrow Anatomy 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 208000028659 discharge Diseases 0.000 description 6
- 208000032839 leukemia Diseases 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000011132 hemopoiesis Effects 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 210000004103 basophilic normoblast Anatomy 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- CRDNMYFJWFXOCH-UHFFFAOYSA-N indirubin Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002969 morbid Effects 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 206010036067 polydipsia Diseases 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- LKAJKIOFIWVMDJ-IYRCEVNGSA-N Stanazolol Chemical compound C([C@@H]1CC[C@H]2[C@@H]3CC[C@@]([C@]3(CC[C@@H]2[C@@]1(C)C1)C)(O)C)C2=C1C=NN2 LKAJKIOFIWVMDJ-IYRCEVNGSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000014951 hematologic disease Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 229960000912 stanozolol Drugs 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 206010000242 Abortion threatened Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010042170 Strangury Diseases 0.000 description 2
- 208000005985 Threatened Abortion Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 238000011221 initial treatment Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
- 208000036566 Erythroleukaemia Diseases 0.000 description 1
- 208000032027 Essential Thrombocythemia Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010061187 Haematopoietic neoplasm Diseases 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001598107 Imperata Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023138 Jaundice neonatal Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 201000006346 Neonatal Jaundice Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010038270 Refractory anaemia with an excess of blasts Diseases 0.000 description 1
- 208000033501 Refractory anemia with excess blasts Diseases 0.000 description 1
- 208000032411 Refractory with Excess of Blasts Anemia Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000021841 acute erythroid leukemia Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001663 anti-spastic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009583 bone marrow aspiration Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002296 eclampsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 230000005977 kidney dysfunction Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000016586 myelodysplastic syndrome with excess blasts Diseases 0.000 description 1
- 206010028537 myelofibrosis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000003924 normoblast Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510286547.7A CN105012725B (zh) | 2015-05-30 | 2015-05-30 | 一种治疗骨髓增生异常综合症的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510286547.7A CN105012725B (zh) | 2015-05-30 | 2015-05-30 | 一种治疗骨髓增生异常综合症的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105012725A CN105012725A (zh) | 2015-11-04 |
CN105012725B true CN105012725B (zh) | 2019-02-12 |
Family
ID=54403265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510286547.7A Active CN105012725B (zh) | 2015-05-30 | 2015-05-30 | 一种治疗骨髓增生异常综合症的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105012725B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102274417A (zh) * | 2011-07-28 | 2011-12-14 | 魏如庆 | 治疗再生障碍性贫血的中成药 |
CN102784315A (zh) * | 2011-12-07 | 2012-11-21 | 魏如庆 | 治疗慢性粒细胞白血病的中成药 |
CN103169880A (zh) * | 2011-12-21 | 2013-06-26 | 魏如庆 | 一种治疗骨髓增生异常综合征的中药组合物及其制备方法 |
-
2015
- 2015-05-30 CN CN201510286547.7A patent/CN105012725B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102274417A (zh) * | 2011-07-28 | 2011-12-14 | 魏如庆 | 治疗再生障碍性贫血的中成药 |
CN102784315A (zh) * | 2011-12-07 | 2012-11-21 | 魏如庆 | 治疗慢性粒细胞白血病的中成药 |
CN103169880A (zh) * | 2011-12-21 | 2013-06-26 | 魏如庆 | 一种治疗骨髓增生异常综合征的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
中西医结合治疗急性白血病35例疗效分析;鄢毅;《中国中西医结合杂志》;19951120(第11期);第643-645页 |
中西医结合治疗骨髓增生异常综合征疗效观察;魏如庆等;《世界中西医结合杂志》;20101128;第5卷(第11期);第969-970页 |
Also Published As
Publication number | Publication date |
---|---|
CN105012725A (zh) | 2015-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103405697A (zh) | 一种治疗肺结核的药物 | |
CN101703684B (zh) | 一种治疗过敏性紫癜的药物及其制备方法 | |
CN101766787B (zh) | 治疗高热、咳喘的灌肠液 | |
CN104474204A (zh) | 一种治疗小儿泄泻的药物组合物 | |
CN102552657B (zh) | 一种用于治疗鸡新城疫病的中药组合物 | |
CN102727676B (zh) | 一种治疗过敏性紫癜的中药组合物及其制备方法和用途 | |
CN105267751A (zh) | 用于治疗气阴两虚型恶性胸腔积液的药物 | |
CN102526209B (zh) | 一种中药固体制剂(剂型) | |
CN102028865A (zh) | 一种化痰止咳的药物组合物及其制备方法 | |
CN105012725B (zh) | 一种治疗骨髓增生异常综合症的中药组合物及其制备方法 | |
CN113577187A (zh) | 一种抗流感的中药组合物、中药提取物及其制备方法和应用 | |
CN104800675A (zh) | 用于治疗活动期溃疡性结肠炎的药物 | |
CN116726083B (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN108815329A (zh) | 一种治疗感冒的中药组合物及其制备方法 | |
CN106334155A (zh) | 一种治疗动甲状腺肿大的中药组合物及其制备方法 | |
CN104688952A (zh) | 一种治疗膀胱湿热型膀胱癌的中药组合物及其制备方法 | |
CN104958530A (zh) | 一种治疗小儿肺炎的中药组合物 | |
CN105311511A (zh) | 一种用于治疗犊牛肺炎的中药组合物及其制备方法和应用 | |
CN104367887A (zh) | 含有酸枣仁的用于治疗腹泻的药物组合物 | |
CN104001127A (zh) | 一种治疗原发性支气管肺癌的多中药混合药 | |
CN102973791A (zh) | 用于治疗单纯性下尿路感染的药物及其制备方法 | |
CN103816265A (zh) | 一种用于治疗泄泻的药物及其制备方法 | |
CN102389509B (zh) | 一种治疗艾滋病的中药组合物及其制备方法 | |
CN104740157A (zh) | 一种治疗小儿哮喘的中药组合物 | |
CN103494924A (zh) | 一种治疗湿热郁结型痤疮的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181220 Address after: 237000 room 105, building 12, Singapore Yuyuan, Lu'an economic and Technological Development Zone, Anhui Applicant after: LU'AN RONGYAO INNOVATION INTELLIGENT TECHNOLOGY CO.,LTD. Address before: 466000 North Weishi Hospital of Daqing Road Bridge, Zhoukou City, Henan Province Applicant before: Wei Ruqing |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240507 Address after: 450052, 3rd Floor, Building 2, No.1 Minghui Road, Mazhai Industrial Park, Erqi District, Zhengzhou City, Henan Province Patentee after: ZHENGZHOU WUXING SHUTI TECHNOLOGY CO.,LTD. Country or region after: China Address before: 237000 room 105, building 12, Singapore Yuyuan, Lu'an economic and Technological Development Zone, Anhui Patentee before: LU'AN RONGYAO INNOVATION INTELLIGENT TECHNOLOGY CO.,LTD. Country or region before: China |